Literature DB >> 10729763

Alteration of telomerase activity in ovarian cancer after chemotherapy.

M Takahashi1, J Kigawa, T Oishi, H Itamochi, M Shimada, S Sato, S Kamazawa, R Akeshima, N Terakawa.   

Abstract

To elucidate the relationship between telomerase activity and chemosensitivity in epithelial ovarian cancer, telomerase activity and telomere length (TRF) were examined before and after chemotherapy. Of 21 patients, 9 patients responded to chemotherapy and 12 did not. The positivity of telomerase activity did not significantly differ between responders and nonresponders. There were no differences in the mean length and the distribution of TRF between the two groups. Those distributions became narrow after chemotherapy in both groups. Seven nonresponders (58.3%) exhibited an increase in telomerase activity after chemotherapy but none of the responders showed an increase in activity. Telomerase activity may relate to chemosensitivity in epithelial ovarian cancer. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10729763     DOI: 10.1159/000010247

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  4 in total

1.  Rapid upregulation of telomerase activity in human leukemia HL-60 cells treated with clinical doses of the DNA-damaging drug etoposide.

Authors:  T J Moriarty; S Dupuis; C Autexier
Journal:  Leukemia       Date:  2002-06       Impact factor: 11.528

2.  The Effect of Cancer Treatments on Telomere Length: A Systematic Review of the Literature.

Authors:  Lisa Gallicchio; Shahinaz M Gadalla; John D Murphy; Naoko I Simonds
Journal:  J Natl Cancer Inst       Date:  2018-10-01       Impact factor: 13.506

3.  Telomerase activity, estrogen receptors (alpha, beta), Bcl-2 expression in human breast cancer and treatment response.

Authors:  Blanca Murillo-Ortiz; Horacio Astudillo-De la Vega; Sebastian Castillo-Medina; J M Malacara; Luis Benitez-Bribiesca
Journal:  BMC Cancer       Date:  2006-08-15       Impact factor: 4.430

4.  Telomerase confers resistance to caspase-mediated apoptosis.

Authors:  Yira Bermudez; Diana Erasso; Nicole C Johnson; Michelle Y Alfonso; Nancy E Lowell; Patricia A Kruk
Journal:  Clin Interv Aging       Date:  2006       Impact factor: 4.458

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.